Focusing on the native matrix proteins in calcific aortic valve stenosis

N Anousakis-Vlachochristou, D Athanasiadou… - Basic to Translational …, 2023 - jacc.org
Calcific aortic valve stenosis (CAVS) is a widespread valvular heart disease affecting people
in aging societies, primarily characterized by fibrosis, inflammation, and progressive …

[HTML][HTML] Matricellular proteins: from cardiac homeostasis to immune regulation

L Meng, H Chen, J Zhang, Y Wu, Y Xu - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Tissue repair after myocardial injury is a complex process involving changes in all aspects of
the myocardial tissue, including the extracellular matrix (ECM). The ECM is composed of …

An injectable dental pulp-derived decellularized matrix hydrogel promotes dentin repair through modulation of macrophage response

P Yi, S Chen, Y Zhao, W Ku, H Lu, D Yu, W Zhao - Biomaterials Advances, 2024 - Elsevier
Maintaining the viability of damaged pulp is critical in clinical dentistry. Pulp cap**, by
placing dental material over the exposed pulp, is a main approach to promote pulp-dentin …

Integrin β1–rich extracellular vesicles of kidney recruit Fn1+ macrophages to aggravate ischemia-reperfusion–induced inflammation

W Wang, X Ren, X Chen, Q Hong, G Cai - JCI insight, 2024 - pmc.ncbi.nlm.nih.gov
Ischemia-reperfusion injury–induced (IRI-induced) acute kidney injury is accompanied by
mononuclear phagocyte (MP) invasion and inflammation. However, systematic analysis of …

[HTML][HTML] Multiscale analysis of human tissue engineered matrices for next generation heart valve applications

N Poulis, P Breitenstein, S Hofstede, SP Hoerstrup… - Acta Biomaterialia, 2023 - Elsevier
Human tissue-engineered matrices (hTEMs) have been proposed as a promising approach
for in situ tissue engineered heart valves (TEHVs). However, there is still a limited …

Development of an iPSC-derived tissue-resident macrophage-based platform for the in vitro immunocompatibility assessment of human tissue engineered matrices

N Poulis, M Martin, SP Hoerstrup, MY Emmert… - Scientific Reports, 2024 - nature.com
Upon implanting tissue-engineered heart valves (TEHVs), blood-derived macrophages are
believed to orchestrate the remodeling process. They initiate the immune response and …

Valvulogenesis of a living, innervated pulmonary root induced by an acellular scaffold

MH Yacoub, YT Tseng, J Kluin, A Vis, U Stock… - Communications …, 2023 - nature.com
Heart valve disease is a major cause of mortality and morbidity worldwide with no effective
medical therapy and no ideal valve substitute emulating the extremely sophisticated …

Cardiovascular protection with a long-acting GLP-1 receptor agonist liraglutide: an experimental update

C Vandemark, J Nguyen, ZQ Zhao - Molecules, 2023 - mdpi.com
Angiotensin II (Ang II), a peptide hormone generated as part of the renin–angiotensin
system, has been implicated in the pathophysiology of many cardiovascular diseases such …

Non-immune factors cause prolonged myofibroblast phenotype in implanted synthetic heart valve scaffolds

Y Snyder, FA Mann, J Middleton, T Murashita… - Applied Materials …, 2024 - Elsevier
The clinical application of heart valve scaffolds is hindered by complications associated with
the activation of valvular interstitial cell-like (VIC-like) cells and their transdifferentiation into …

Folic acid modified silver nanoparticles promote endothelialization and inhibit calcification of decellularized heart valves by immunomodulation with anti-bacteria …

P Song, Y Wu, M Fan, X Chen, M Dong, W Qiao… - Biomaterials …, 2025 - Elsevier
Xenogeneic decellularized heart valves (DHVs) have become one of the most commonly
used scaffolds for tissue engineered heart valves (TEHVs) due to extensive resources and …